Literature DB >> 25367407

Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.

Jianxing Liu1, Pan Chen, Meihua Guo, Lechun Lu, Lihua Li.   

Abstract

In previous study, we have found the catechol-O-methyltransferase (COMT) Val158Met polymorphism may be associated with the risk of Parkinson's disease (PD) in Asians, especially Japanese population. In this study, we further evaluated the associations of PD wearing-off susceptibility with COMT polymorphisms. We carried out a retrieval of studies and included the relevant studies which met the criteria. After the data were extracted, the Stata software 11.0 was used to analyse the genotype frequencies. A total of five studies were included. The pooled result indicated that genotype AA was significantly associated with the wearing-off risk of PD (AA vs. others: OR = 2.52, 95 % CI 1.21-5.26, P = 0.013; AA vs. GA: OR = 2.51, 95 % CI 1.18-5.34, P = 0.017; AA vs. GG: OR = 2.17, 95 % CI 1.09-4.33, P = 0.027). The results also showed allele A was correlated with PD wearing-off risk (A vs. G: OR = 1.95, 95 % CI 1.18-3.22, P = 0.009). In conclusion, this study suggested that Val158Met polymorphisms in COMT may increase the risk of wearing-off. Further studies with larger sample sizes are needed to confirm our results.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367407     DOI: 10.1007/s10072-014-1998-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

1.  Clinical approach to Parkinson's disease: features, diagnosis, and principles of management.

Authors:  João Massano; Kailash P Bhatia
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease.

Authors:  M Watanabe; S Harada; T Nakamura; N Ohkoshi; K Yoshizawa; A Hayashi; S Shoji
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

Review 3.  Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.

Authors:  Hongying Hao; Ming Shao; Jing An; Chushuang Chen; Xiuli Feng; Shu Xie; Zhuqin Gu; Piu Chan
Journal:  Parkinsonism Relat Disord       Date:  2014-07-04       Impact factor: 4.891

4.  Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.

Authors:  Hui Wu; Fangyi Dong; Ying Wang; Qin Xiao; Qiong Yang; Jing Zhao; Thomas J Quinn; Sheng-di Chen; Jun Liu
Journal:  Parkinsonism Relat Disord       Date:  2014-07-27       Impact factor: 4.891

5.  Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes.

Authors:  A J Shield; B A Thomae; B W Eckloff; E D Wieben; R M Weinshilboum
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

6.  The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations.

Authors:  Lu Lechun; Su Yu; Hou Pengling; Huang Changqi
Journal:  Neurol India       Date:  2013 Jan-Feb       Impact factor: 2.117

  6 in total
  2 in total

1.  Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson's disease.

Authors:  Qin Xiao; Yiwei Qian; Jiujiang Liu; Shaoqing Xu; Xiaodong Yang
Journal:  Transl Neurodegener       Date:  2017-04-26       Impact factor: 8.014

2.  Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease.

Authors:  Cuiping Zhao; Yihua Wang; Bin Zhang; Yaoxian Yue; Jianyuan Zhang
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.